Patents Assigned to ImaRx Pharmaceutical Corporation
  • Methods for delivering compounds into a cell
    Publication number: 20050080029
    Abstract: The present invention is directed, inter alia, to a method for delivering a compound into a cell comprising administering to the cell the compound to be delivered, an organic halide, and/or a carrier. Ultrasound may also be applied, if desired.
    Type: Application
    Filed: August 20, 2003
    Publication date: April 14, 2005
    Applicant: ImaRx Pharmaceutical Corporation
    Inventors: Evan Unger, Thomas McCreery
  • Methods for delivering compounds into a cell
    Patent number: 6638767
    Abstract: The present invention is directed, inter alia, to a method for delivering a compound into a cell comprising administering to the cell the compound to be delivered, an organic halide, and/or a carrier. Ultrasound may also be applied, if desired.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: October 28, 2003
    Assignee: ImaRx Pharmaceutical Corporation
    Inventors: Evan C. Unger, Thomas McCreery
  • Methods for delivering compounds into a cell
    Publication number: 20010031740
    Abstract: The present invention is directed, inter alia, to a method for delivering a compound into a cell comprising administering to the cell the compound to be delivered, an organic halide, and/or a carrier. Ultrasound may also be applied, if desired.
    Type: Application
    Filed: December 21, 2000
    Publication date: October 18, 2001
    Applicant: ImaRX Pharmaceutical Corporation
    Inventors: Evan C. Unger, Thomas McCreery
  • Liposoluble heterocyclic compounds useful as magnetic resonance imaging agents
    Patent number: 5624662
    Abstract: Novel complexes of paramagnetic ions and compounds bearing long acyl chains have been synthesized as magnetic resonance imaging contrast agents. These novel liposoluble contrast agents may be administered alone, or with lipids, suspending agents or other additives. The lipids may be in the form of liposomes, micelles or lipid emulsions. The contrast agents of the invention have particular use in magnetic resonance imaging of the liver, blood pool and reticuloendothelial system.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 29, 1997
    Assignee: ImaRx Pharmaceutical Corporation
    Inventors: Evan C. Unger, DeKang Shen